Showing results (31-40 of 272) with videos related to
Sort By:
Pageof 28
Current Drug Targets|July 23, 2011
Targeting aurora kinases in cancer treatmentKevin R Kelly, Jeffrey Ecsedy, Devalingam Mahalingam, et al.Journal of Gastrointestinal Oncology|April 29, 2014
Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trialsSukeshi R Patel, Anand B Karnad, Norma S Ketchum, et al.Journal of Gastrointestinal Oncology|June 2, 2015
Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunctionRaed Al-Rajabi, Sukeshi Patel, Norma S Ketchum, et al.Molecular Cancer Research : MCR|August 31, 2013
Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progressionPramod S Gowda, Jianhong D Deng, Sweta Mishra, et al.Cancers|June 20, 2019
A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular CarcinomaDevalingam Mahalingam, Julio Peguero, Putao Cen, et al.Hematology (Amsterdam, Netherlands)|July 4, 2007
Troxacitabine in leukemiaRonan Swords, Effrosyni Apostolidou, Francis GilesCancer|November 6, 2003
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemiaFrancis Giles, Elihu Estey, Susan O'BrienMedical Oncology (Northwood, London, England)|August 4, 2007
Recent advances in the diagnosis and therapy of Richter's syndromeRonan Swords, John Bruzzi, Francis GilesLeukemia & Lymphoma|April 12, 2003
Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromesAlvaro Aguayo, Francis Giles, Maher AlbitarCurrent Hematology Reports|April 17, 2004
Myelodysplastic syndrome: from morphology to biologyMaher Albitar, Weidong Zhou, Francis GilesPageof 28